The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Eisai; Lilly; Roche; SERVIER
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche; SERVIER
Sequential nab-paclitaxel/gemcitabine followed by modified FOLFOX for first-line metastatic pancreatic cancer: The SEQUENCE trial.
 
Alfredo Carrato
Consulting or Advisory Role - Baxter
Travel, Accommodations, Expenses - MSD Oncology
 
Roberto Pazo-Cid
No Relationships to Disclose
 
Teresa Macarulla
Consulting or Advisory Role - Ability Pharma; Advance Medical; Amgen; Aptitude Health; AstraZeneca; Basilea; Baxter; BioLineRX; Celgene; Eisai; Ellipses Pharma; Genzyme; Hirslanden/GITZ; Imedex; Incyte; Ipsen; Janssen; Lilly; Medscape; Menarini; MFAR, Marketing Farmacéutico & Investigación Clínica; MSD; Novocure; Paraxel; Polaris Consulting; PPD; Prime Oncology; QED Therapeutics; Roche; Sanofi/Aventis; Scilink Comunicación Científica SC; SERVIER; Surface Oncology; Swedish Orphan Biovitrum; Zymeworks
Research Funding - Abbvie (Inst); Ability Pharma (Inst); Agios (Inst); Amc Medical Research (Inst); Amgen (Inst); Armo Biosciences (Inst); ASLAN Pharmaceuticals (Inst); AstraZeneca (Inst); Basilea Pharmaceutical (Inst); Bayer (Inst); Beigene (Inst); BiolineRx (Inst); Blueprint Medicines (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (BMS) (Inst); Cantargia AB (Inst); Celgene (Inst); Eisai (Inst); ERYTECH Pharma (Inst); Fibrogen (Inst); Genentech (Inst); Halozyme (Inst); Immunomedics (Inst); Incyte (Inst); Ipsen (Inst); Keralty Group (Inst); Lilly (Inst); Loxo (Inst); Medimmune (Inst); Merck Sharp & Dohme (Inst); Merrimack (Inst); Millennium (Inst); Nelum Corp. (Inst); Novartis (Inst); Novocure (Inst); OncoMed (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche (Inst); Roche (Inst); VCN Biosciences (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - Celgene; H3 Biomedicine; Incyte; Merck; Prime Oncology; Sanofi; SERVIER
 
Javier Gallego
Consulting or Advisory Role - AAA HealthCare; Amgen; Bayer; Bristol-Myers Squibb; Celgene; Eisai Europe; Lilly; Merck Serono; Roche
Speakers' Bureau - Amgen; Ipsen; Lilly; Novartis
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst)
Expert Testimony - Bayer; Lilly
Travel, Accommodations, Expenses - Amgen; Novartis; Roche
Other Relationship - Amgen; Amgen; Bristol-Myers Squibb; Merck
 
Paula Jiménez-Fonseca
No Relationships to Disclose
 
Fernando Rivera
No Relationships to Disclose
 
Maria Teresa Cano
No Relationships to Disclose
 
Mercedes Rodríguez Garrote
Honoraria - Bristol-Myers Squibb; Merck
 
Carles Pericay
No Relationships to Disclose
 
Inmaculada Diaz
Consulting or Advisory Role - Incyte; Lilly
Speakers' Bureau - Bristol-Myers Squibb; SERVIER
 
Laura Layos
Consulting or Advisory Role - Merck; Sanofi
Travel, Accommodations, Expenses - Amgen; IPSEN; Merck; Roche
 
Begoña Graña
No Relationships to Disclose
 
Vega Iranzo
No Relationships to Disclose
 
Inmaculada Gallego-Jimenez
Expert Testimony - AstraZeneca Spain; Bayer; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca Spain; MSD
 
Rocio Garcia-Carbonero
Honoraria - Advanced Accelerator Applications; Advanz Pharma; Amgen; AstraZeneca (I); Bayer; BMS; Boehringer Ingelheim (I); Gilead Sciences (I); Hutchmed; Ipsen; Lilly (I); Merck; Midatech Pharma; Mirati Therapeutics (I); MSD; Novartis; Pfizer (I); PharmaMar; Roche (I); Sanofi (I); Servier; Takeda (I)
Consulting or Advisory Role - HMP
Research Funding - BMS (Inst); MSD (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Merck; MSD; Roche
 
Maria Alvarez Alejandro
No Relationships to Disclose
 
Inmaculada Ruiz de Mena
No Relationships to Disclose
 
CARMEN GUILLEN PONCE
Research Funding - AstraZeneca (Inst); Boston Scientific (Inst); ERYTECH Pharma (Inst); QED Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; General Electric; Merck Serono; Sanofi/Aventis
 
Enrique Aranda
Consulting or Advisory Role - Amgen; Bayer; Celgene; Merck; Roche; Sanofi